NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2021.
- Key Activities for the Quarter:
In April 2021, the Company delivered approximately $7 million of oral TPOXX to PHAC under the contract that was awarded in January 2021 (2021 PHAC Contract).
- The FDA review process will typically take 10 months for this type of submission.
- During the second quarter of 2021, SIGA repurchased approximately 1.0 million shares of its common stock, for approximately $6.6 million.
- SIGA will host a conference call and webcast to provide a business update today, Thursday, August 5, 2021, at 4:30 P.M.